Power3 Medical Products, Inc. (OTC:PWRM)
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.
Power3 Medical Products, Inc. announced recently that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (NASDAQ:ICAD) in Honolulu, Hawaii.
These presentations discussed NuroPro, PWRM’s diagnostic test, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
Alzheimer’s disease isn’t an ordinary part of getting older, even though greatest known risk factor is increasing age, along with the largest part of people today with Alzheimer’s tend to be 65 and older.
But Alzheimer’s isnt just a sickness of old age.
Up to 5 % of people with the sickness currently have early-onset Alzheimer’s (also referred to as younger-onset), which frequently appears when ever someone is within his or her 40s or 50s.
PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas.
To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
After cancer of the skin, breast cancer is easily the most typical cancer found in women in the US. However, breast cancer statistics have dropped lately, despite the fact that medical experts are not sure as to why. Nevertheless, with regard to numerous women, breast cancer is actually the health issues they dread a great deal of.
Breast cancer is a melanoma in which cells in the breast separate and develop without regulation. Around Eighty-five percent of breast cancer occurances start out within the mammary ducts, though approximately 15% arise within the lobules. Tumors inside the chest have a tendency to develop little by little. By the point a mass might be large enough so that you can feel it, it could have been developing for as long as ten years. However, a few tumors may be aggressive, and increase considerably faster.
PWRM continues to discover new ways to test for Alzheimers, Parkinsons, and Breast Cancer!
To learn more about PWRM visit: http://www.Power3Medical.com
Metropolitan Health Networks Inc. (AMEX:MDF) announced that its wholly owned subsidiary, Metcare of Florida, Inc., (“Metcare”) has entered into a definitive agreement to acquire the assets and assume certain liabilities of Suzann Leslie, D.O., P.A.Dr. Leslie is a board eligible family practice physician who has developed a successful, high quality primary care practice, which includes approximately 400 Humana Medicare Advantage members, in Stuart, Florida. The practice is currently contracted with Metcare and its Humana membership is already included in Metcare’s customer base. Terms of the transaction, which is expected to close within 90 days, were not disclosed.
Metropolitan Health Networks, Inc., through its subsidiaries, operates provider service networks (PSN) in the United States. Its PSN provides and arranges healthcare services to Medicare Advantage beneficiaries who participate in a Medicare Advantage plan. The company offers Medicare, a national health insurance program that covers the cost of hospitalization, medical care, and related health services for the U.S. citizens aged 65 and older, qualifying disabled persons, and persons suffering from end-staged renal disease.****************************
Hooper Holmes Inc. (AMEX:HH) announced that Tom Watford, President and Chief Operating Officer of Santa Rosa Consulting, has joined the Company's Board of Directors."Tom has a unique track record of success in corporate finance, operations and healthcare IT," said Larry Ferguson, Chairman of the Board of Hooper Holmes. "He's going to be a terrific Director, and we're pleased to have the benefit of both his healthcare industry and financial turnaround experience."
Hooper Holmes, Inc., together with its subsidiaries, provides outsourced risk assessment services to the life and health insurance industry in the United States. The company?s Health Information division assists insurance companies, their affiliated agents, and independent agents and brokers in gathering statistical probabilities of death and illness or disease. It provides paramedical and medical examinations of applicants for insurance, primarily life insurance, through a network of paramedical examiners, including phlebotomists, registered nurses, licensed practitioner nurses, emergency medical technicians, and other medically trained professionals.****************************
Intellicheck Mobilisa, Inc. (AMEX:IDN) recently presented the Company’s current status and future goals at the 2010 Imperial Capital Security Investor Conference held at The Ritz-Carlton in Washington, DC this December. At the conference, Mr. Williams spoke to other senior executives from leading public and privately held companies in the security industry, government and Department of Homeland Security representatives, institutional investors and lenders. The purpose of the conference is to provide solutions across the entire spectrum of the security sector, from cutting-edge technology to traditional physical security companies, including companies focused on the Homeland Security, Residential and Enterprise markets.
Intellicheck Mobilisa, Inc. develops and markets wireless technology and identity systems to mobile and handheld wireless devices for the government, military, and commercial markets. The company?s commercial identification products include IDvCheck, a document verification software for reading and verifying, in one swipe or scan, the encoded format contained on the U.S. and Canadian driver licenses, state issued non-driver identification cards, and military IDs.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).